Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v14-FR
Language French French
Date Updated 2022-06-17 2022-04-29
Drug Identification Number 02245669 02245669
Brand name APO-SALBUTAMOL HFA APO-SALBUTAMOL HFA
Common or Proper name SALBUTAMOL HFA SALBUTAMOL HFA
Company Name APOTEX INC APOTEX INC
Ingredients SALBUTAMOL SALBUTAMOL
Strength(s) 100MCG 100MCG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 200MD 200MD
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-04-15 2022-04-15
Actual start date 2022-04-12 2022-04-12
Estimated end date 2022-06-17 2022-06-17
Actual end date 2022-06-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments There will be limited inventory releases before full recovery in June There will be limited inventory releases before full recovery in June
Health Canada comments